DUBLIN–(BUSINESS WIRE)–Jan 27, 2021–
The "Pen Needles Market By Type, By Length, By Therapy, By Usability, By Distribution Channel, And By End Use, By Region, Segment Forecasts To 2027" report has been added to ResearchAndMarkets.com’s offering.
The global pen needles market is forecast to reach USD 2.66 Billion by 2027, from USD 1.53 Billion in 2019
The increasing elderly populations, rising incidences of obesity-related diabetes, and a favorable reimbursement scenario are the key factors leading to the burgeoning growth in market demand.
Pen needles are used for drug administration for many diseases and are used by both healthcare professionals and patients themselves. They have become popularly accepted with the advancements in therapy and a supportive reimbursement structure in many nations.
According to the World Health Organization (WHO), from 2015 to 2050, the aged population across the globe will be rise from 12% to 22% of the total global population. Owing to this, the incidence of target diseases such as chronic diseases and cancer is expected to grow and, in return, will boost the demand.
An increase in healthcare expenditure across the globe also supports the adoption of user-friendly technologies. According to the American Diabetes Association, the annual healthcare cost in the U.S. increased by 26% during the last five years due to increased diabetes incidences.
North America holds the largest share as of 2019 because of an increasing incidence of diabetes in the region. Government initiatives to spread awareness about the product along with favorable funding from many private players is leading the market growth.
Companies adopt both organic and inorganic growth strategies in order to ensure a steady pattern of growth. Acquisitions and mergers are commonly witnessed in the industry. In December 2017, BD acquired Bard to make use of the latter’s product portfolio and innovation pipeline.
Key participants include Becton, Dickinson and Company, Novo Nordisk A/S, Ypsomed Holding AG, B. Braun Melsungen AG, HTL-Strefa S.A., Terumo Corporation, Owen Mumford Ltd., Allison Medical Inc., Ultimed, Inc., and Arkray, Inc., among others.
Key Topics Covered:
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Pen Needles Market Segmentation & Impact Analysis
4.1. Pen Needles Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
18.104.22.168. Growing number of diabetic population
22.214.171.124. Introduction of technologically advanced products
126.96.36.199. Comparative advantage of needle pens over syringes and vials
4.2.3. Market restraints analysis
188.8.131.52. Availability of alternative drug delivery methods
184.108.40.206. Rising incidence of needlestick injuries
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter’s Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price trend Analysis
Chapter 5. Pen Needles By Type Insights & Trends
5.1. Type Dynamics & Market Share, 2019 & 2026
5.2. Standard pen needles
5.3. Safety pen needles
Chapter 6. Pen Needles By Length Insights & Trends
6.1. Length Dynamics & Market Share, 2019 & 2026
Chapter 7. Pen Needles By Therapy Insights & Trends
7.1. Therapy Dynamics & Market Share, 2019 & 2026
7.2. Insulin therapy
7.3. Glucagon-like peptide-1 (glp-1) therapy
7.4. Growth hormone therapy
Chapter 8. Pen Needles By Usability Insights & Trends
8.1. Usability Dynamics & Market Share, 2019 & 2026
8.2. Reusable Pens
8.3. Disposable Pens
Chapter 9. Pen Needles By Distribution Channel Insights & Trends
9.1. Distribution Channel Dynamics & Market Share, 2019 & 2026
Chapter 10. Pen Needles By End Use Insights & Trends
10.1. End Use Dynamics & Market Share, 2019 & 2026
10.2. Home healthcare
Chapter 11. Pen Needles Market Regional Outlook
11.1. Pen Needles Market share By Region, 2019 & 2026
Chapter 12. Competitive Landscape
12.1. Market Revenue Share By Manufacturers
12.2. Manufacturing Cost Breakdown Analysis
12.3. Mergers & Acquisitions
12.4. Market positioning
12.5. Strategy Benchmarking
12.6. Vendor Landscape
Chapter 13. Company Profiles
- Dickinson Company
- Novo Nordisk A/S
- Ypsomed Holding AG
- B. Braun Melsungen AG
- HTL-Strefa S.A.
- Terumo Corporation
- Owen Mumford Ltd.
- Allison Medical Inc.
- Ultimed Inc.
- Arkray Inc.,
For more information about this report visit https://www.researchandmarkets.com/r/tgozoo
View source version on businesswire.com:https://www.businesswire.com/news/home/20210127005619/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: DIABETES MEDICAL DEVICES HOSPITALS HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 01/27/2021 09:57 AM/DISC: 01/27/2021 09:57 AM